- Home
- ALEC vs LCNB Comparison
ALEC vs LCNB Comparison
Compare ALEC & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALEC | LCNB |
|---|---|---|
| Founded | 2013 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.2M | 234.5M |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ALEC | LCNB |
|---|---|---|
| Price | $2.18 | $15.63 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 437.9K | 16.3K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.43% |
| EPS Growth | N/A | ★ 68.04 |
| EPS | N/A | ★ 0.31 |
| Revenue | ★ $21,045,000.00 | $6,445,000.00 |
| Revenue This Year | $2.03 | $8.50 |
| Revenue Next Year | $29.87 | $3.66 |
| P/E Ratio | ★ N/A | $50.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $13.75 |
| 52 Week High | $3.40 | $17.89 |
Technical Indicators
Market Signals| Indicator | ALEC | LCNB |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 43.02 |
| Support Level | $1.89 | $15.26 |
| Resistance Level | $2.57 | $15.88 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 24.46 | 30.66 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.